Moderna swells vaccine supply in deal with Biotech startup National Intelligence

USA – Moderna is expanding production of the genetic backbone of its coronavirus vaccine, signing a multi-year deal with the new biotech manufacturing startup National Resilience. The agreement, announced by Resilience, follows the company’s recent application for FDA authorization of a half dose of its vaccine as a third, booster shot six months after initial vaccination. While Resilience’s announcement did not specify how much the deal would boost Moderna’s production, the vaccine maker forecast earlier this year it could make between 800 million and one billion doses in 2021 and…

Read More